Skip to Main Content

Advertisement

Skip Nav Destination

Abstract P5-19-09: Preliminary results from a phase 2 single-arm study of enzalutamide, an androgen receptor (AR) inhibitor, in advanced AR+ triple-negative breast cancer (TNBC)

Cancer Res (2015) 75 (9_Supplement): P5-19-09.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Binghe Xu
  • Xichun Hu
  • Jifeng Feng
  • Cuizhi Geng
  • Feng Jin
  • Hongyuan Li
  • Man Li
  • Qing Li
  • Ning Liao
  • Donggeng Liu
  • Jian Liu
  • Qiang Liu
  • Jinsong Lu
  • Zhenzhen Liu
  • Fei Ma
  • Quchang Ouyang
  • Yueyin Pan
  • Kunwei Shen
  • Tao Sun
  • Yuee Teng
  • Zhongsheng Tong
  • Biyun Wang
  • Haibo Wang
  • Shulian Wang
  • Shusen Wang
  • Tao Wang
  • Xiang Wang
  • Xiaojia Wang
  • Yongsheng Wang
  • Zhonghua Wang
  • Jiong Wu
  • Min Yan
  • Junlan Yang
  • Yongmei Yin
  • Peng Yuan
  • Jin Zhang
  • Pin Zhang
  • Qingyuan Zhang
  • Hong Zheng
Cancer (2020) 126 (S16): 3867.
  • A. de Nonneville
  • A. Gonçalves
Oncologie (2019) 21 (1-4): 33.
  • Lynn Jongen
  • Robert Paridaens
  • Giuseppe Floris
  • Hans Wildiers
  • Patrick Neven
Breast Cancer Research and Treatment (2016) 155 (3): 603.
  • Gabriel Rinnerthaler
Wiener klinisches Magazin (2015) 18 (6): 212.
Close Modal

or Create an Account

Close Modal
Close Modal